Answers are grounded in this paper and cite their sources.
Our study assessed adolescents' and emerging adults' (ages 14-24 years) preferences for opt-out gonorrhea and chlamydia screening compared with risk-based screening. Most participants (93%) preferred opt-out gonorrhea and chlamydia testing compared with risk-based testing (6%), and opt-out testing was associated with less sexually transmitted infection-related stigma ( P < 0.05).
No takes yet. Share an insight, caveat, or question.
Reingold et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: